ConductScience.org, home

Trial · NCT00884221

Results by group52

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Ongoing Pregnancy After One Fresh Embryo Replacement Cycle, Intention-to-treat (ITT) Analysis SetHighly Purified Menotrophin29Standard Deviation 2.3Percentage of participants
Ongoing Pregnancy After One Fresh Embryo Replacement Cycle, Intention-to-treat (ITT) Analysis SetRecombinant FSH27Standard Deviation 2.3Percentage of participants
Endocrine Profile (Estradiol), Intention-to-treat (ITT) Analysis SetHighly Purified Menotrophin8797Standard Deviation 6030pmol/L
Endocrine Profile (Estradiol), Intention-to-treat (ITT) Analysis SetRecombinant FSH7022Standard Deviation 4945pmol/L
Endocrine Profile (FSH), Intention-to-treat (ITT) Analysis SetHighly Purified Menotrophin15.7Standard Deviation 4.1IU/L
Endocrine Profile (FSH), Intention-to-treat (ITT) Analysis SetRecombinant FSH12.6Standard Deviation 3.7IU/L
Endocrine Profile (Free Androgen Index), Intention-to-treat (ITT) Analysis SetHighly Purified Menotrophin2.8Standard Deviation 2.0Percentage of participants
Endocrine Profile (Free Androgen Index), Intention-to-treat (ITT) Analysis SetRecombinant FSH2.5Standard Deviation 2.2Percentage of participants
Endocrine Profile (Luteinizing Hormone), Intention-to-treat (ITT) Analysis SetHighly Purified Menotrophin2.8Standard Deviation 2.8IU/L
Endocrine Profile (Luteinizing Hormone), Intention-to-treat (ITT) Analysis SetRecombinant FSH2.1Standard Deviation 1.6IU/L
Endocrine Profile (Progesterone), Intention-to-treat (ITT) Analysis SetHighly Purified Menotrophin3.1Standard Deviation 3.4nmol/L
Endocrine Profile (Progesterone), Intention-to-treat (ITT) Analysis SetRecombinant FSH3.1Standard Deviation 3.3nmol/L
Ongoing Pregnancy After One Fresh Embryo Replacement Cycle, Per-protocol (PP) Analysis SetHighly Purified Menotrophin30Standard Deviation 2.5Percentage of participants
Ongoing Pregnancy After One Fresh Embryo Replacement Cycle, Per-protocol (PP) Analysis SetRecombinant FSH27Standard Deviation 2.4Percentage of participants
Endocrine Profile (Prolactin), Intention-to-treat (ITT) Analysis SetHighly Purified Menotrophin1544Standard Deviation 770pmol/L
Endocrine Profile (Prolactin), Intention-to-treat (ITT) Analysis SetRecombinant FSH1410Standard Deviation 689pmol/L
Endocrine Profile (Sex Hormone Binding Globulin), Intention-to-treat (ITT) Analysis SetHighly Purified Menotrophin111Standard Deviation 51nmol/L
Endocrine Profile (Sex Hormone Binding Globulin), Intention-to-treat (ITT) Analysis SetRecombinant FSH107Standard Deviation 48nmol/L
Endocrine Profile (Testosterone), Intention-to-treat (ITT) Analysis SetHighly Purified Menotrophin2.5Standard Deviation 1.2nmol/L
Endocrine Profile (Testosterone), Intention-to-treat (ITT) Analysis SetRecombinant FSH2.1Standard Deviation 1.0nmol/L

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00884221/results